Emtricitabin og tenofovir udskilles via nyrerne, og eksponeringen over for emtricitabin og tenofovir øges hos patienter med nyredysfunktion.
Emtricitabine and tenofovir are eliminated by renal excretion and the exposure to emtricitabine and tenofovir increases in patients with renal dysfunction.